ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) - Equities researchers at HC Wainwright issued their FY2025 earnings per share estimates for shares of ASP Isotopes in a research note issued to investors on Wednesday, April 17th. HC Wainwright analyst H. Ihle expects that the company will post earnings of ($0.07) per share for the year. HC Wainwright has a "Buy" rating and a $5.50 price objective on the stock. The consensus estimate for ASP Isotopes' current full-year earnings is $0.07 per share.
ASP Isotopes Stock Up 1.6 %
Shares of ASP Isotopes stock traded up $0.05 on Thursday, reaching $3.09. 871,471 shares of the company were exchanged, compared to its average volume of 595,866. ASP Isotopes has a one year low of $0.28 and a one year high of $4.97. The company has a market capitalization of $151.16 million, a price-to-earnings ratio of -6.45 and a beta of 5.03. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.01. The company has a 50-day moving average of $3.67 and a 200 day moving average of $2.38.
Institutional Investors Weigh In On ASP Isotopes
Institutional investors and hedge funds have recently made changes to their positions in the stock. Armistice Capital LLC acquired a new stake in ASP Isotopes during the 1st quarter valued at $2,702,000. Renaissance Technologies LLC bought a new position in shares of ASP Isotopes in the second quarter valued at about $272,000. GSA Capital Partners LLP acquired a new stake in shares of ASP Isotopes during the 4th quarter worth about $608,000. Vanguard Group Inc. lifted its stake in shares of ASP Isotopes by 761.7% during the 4th quarter. Vanguard Group Inc. now owns 176,314 shares of the company's stock worth $316,000 after buying an additional 155,853 shares during the last quarter. Finally, Rathbones Group PLC acquired a new stake in shares of ASP Isotopes during the 4th quarter worth about $272,000. Institutional investors own 16.80% of the company's stock.
Insider Transactions at ASP Isotopes
In related news, Director Robert John Andrew Ryan acquired 15,596 shares of the company's stock in a transaction dated Monday, January 29th. The shares were bought at an average price of $2.35 per share, for a total transaction of $36,650.60. Following the purchase, the director now directly owns 537,055 shares in the company, valued at approximately $1,262,079.25. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 26.30% of the company's stock.
About ASP Isotopes
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
See Also
Before you consider ASP Isotopes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.
While ASP Isotopes currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
